JAK2 and hepatocellular carcinoma: Carboxypeptidase X M14 family member 2 overexpression promotes proliferation and migration, predicts an unfavorable prognosis of osteosarcoma (31), and accelerates progression through the regulation of the gp130/JAK2/Stat1 pathway in hepatocellular carcinoma (32).